Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals

NCT05763940 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaIndex (OmegaQuant) research.

Conditions

  • Dry Eye Syndromes
  • Age-Related Macular Degeneration
  • Omega 3 Index

Interventions

DIETARY_SUPPLEMENT

OmegaBoost

An ultra-pure omega-3 fish oil supplement with no fishy aftertaste and no fish burps. 10x more omega-3 from fish oil than the leading omega-3 gummies. Gel bites have better absorption than ordinary, hard-to-swallow fish oil pills.

DIETARY_SUPPLEMENT

Nature Made (soft gel)

A commercially-available omega-3 soft gel formula

DIETARY_SUPPLEMENT

Nature Made (gummy)

A commercially-available omega-3 formula in gummy form

Sponsors & Collaborators

  • Guardion Health Sciences, Inc.

    collaborator INDUSTRY
  • Western University of Health Sciences

    lead OTHER

Principal Investigators

  • Pinakin Gunvant Davey, PhD, OD · Western University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2024-05-25
Completion
2024-06-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763940 on ClinicalTrials.gov